ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CODX Co Diagnostics Inc

1.4774
0.0274 (1.89%)
Last Updated: 16:32:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Co Diagnostics Inc NASDAQ:CODX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0274 1.89% 1.4774 1.45 1.48 1.5899 1.45 1.47 84,955 16:32:00

Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand

16/08/2023 4:30pm

PR Newswire (US)


Co Diagnostics (NASDAQ:CODX)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Co Diagnostics Charts.

SALT LAKE CITY, Aug. 16, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at Asia Health/Medlab Asia 2023 from August 16-18 at the IMPACT Exhibition Center in Bangkok, Thailand.

(PRNewsfoto/Co-Diagnostics)

The Asia Health/Medlab Asia conference is intended to bring together healthcare and laboratory communities to network and do business in what the conference website describes as the region's most valuable platform for the healthcare industry, with over 7,500 visitors, delegates, distributors, and senior lab and healthcare executives expected to be in attendance.

The Company's booth will showcase Co-Diagnostics' state-of-the-art Co-Primer™ PCR technology and infectious disease products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform which is subject to FDA review and is not available for sale.

Additional details, including registration information, can be found here.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medlab-asia-conference-in-bangkok-thailand-301902656.html

SOURCE Co-Diagnostics

Copyright 2023 PR Newswire

1 Year Co Diagnostics Chart

1 Year Co Diagnostics Chart

1 Month Co Diagnostics Chart

1 Month Co Diagnostics Chart

Your Recent History

Delayed Upgrade Clock